相关实验视频

Updated: Jun 28, 2025

Multi-step Variable Height Photolithography for Valved Multilayer Microfluidic Devices

Multi-step Variable Height Photolithography for Valved Multilayer Microfluidic Devices

Published on: January 27, 2017

微环境调节的双水友性涂层用于玻璃眼膜表面工程

Shimeng Zhang¹, Yejia Liu², Linhua Li³

¹The Department of Ophthalmology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China; Sichuan Provincial Key Laboratory for Human Disease Gene Study, the Department of Medical Genetics, the Institute of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology, Chengdu, China.

Acta biomaterialia

|April 11, 2024

概括

这项研究开发了一种双性涂层用于玻璃眼膜 (GVs),以减少纤维化和提高生物相容性. 创新的表面工程在体内显著抑制了炎症和纤维化,提高了GV的性能.

科学领域:

生物材料科学生物材料科学
表面工程是什么?表面工程是什么?
眼科医生眼科眼科

背景情况:

玻璃眼膜 (GVs) 对于玻璃眼治疗至关重要,但在植入后纤维化方面面临挑战,限制了长期的疗效.
植入GVs周围的纤维化和炎症反应可能导致设备故障和治疗效果降低.

研究的目的:

为 (SR) 玻璃眼门设计一个微环境调节的,双水友的防涂层.
通过减轻纤维化和炎症,增强GVs的生物相容性和长期成功.

主要方法:

在SR上开发了超性多多巴胺 (SPD) 涂层,利用其抗和抗氧化特性.
利用SPD的光催化活性聚合聚二甲基基乙基胆 (pMPC),创建具有远程抗效应的双水友表面.
通过对抗蛋白质污染,抗氧化,抗炎症和抗纤维增殖的体外试验来评估涂层的性能,随后通过对纤维化减少的体内评估进行体外评估.

主要成果:

双水友性涂层在体外显示出对蛋白质吸附,氧化应激和炎症细胞粘附的显著抵抗力.
在体外研究表明,纤维细胞增殖显著减少,表明抗纤维细胞潜力.
在体内测试证实,涂层SR材料大大抑制了纤维封装,减少了玻璃眼膜植入物周围的炎症和纤维化.

结论:

微环境调节的双水友性涂层有效地提高了膜的生物相容性.
这种表面工程策略在预防纤维化和炎症方面表现有前途,可能会导致对玻璃眼植入物改善长期结果.
开发的涂层为医疗器械表面修改提供了有价值的模型,以提高生物相容性和减少异物反应.

关键词:

纤维化纤维化纤维化眼光障碍眼光障碍眼光障碍眼光障碍玻璃眼的门玻璃眼的门炎症炎症是一种炎症.超性聚多巴胺涂层是超性聚多巴胺涂层

更多相关视频

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...